包容性身体肌肉炎:一个晚期诊断病例报告
Deysi Andrea Hernández-Rivero1, Lisette Bazán-Rodríguez2, María Del Pilar Cruz-Domínguez3
1División Académica Multidisciplinaria de Comalcalco, Universidad Juárez Autónoma de Tabasco, Comalcalco, Tabasco, Mexico.
Reumatologia clinica
|October 29, 2024
概括
包容体肌炎是一种异常性炎症性肌病,表现为肌肉虚弱. 一个案例研究突出了多质神经炎的错误诊断,后来的活检证实了治疗失败后的包容体神经炎.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 包容体肌肉炎 (IBM) 是一种异常性炎症性肌肉病.
- 它的特点是渐进的肌肉衰弱和消化不良.
- 诊断通常涉及肌肉活检显示炎症和边缘真空.
关键词:
肌氨酸激酶酶的作用是什么肌肉的弱点 肌肉的弱点消症 消症 消症异形性炎症性肌肉病变是一种异形性炎症性肌肉病变.包容性身体肌肉炎的包括炎症性肌肉病 (Miopatía inflamatoria idiopática) 是一种病变性肌肉病.肌肉炎是由包括的身体引起的.肌肉疲弱 肌肉疲弱 肌肉疲弱带边的真空孔 (Rimmed vacuoles) 是一个带边的真空孔.瓦库奥拉斯 (vacuolas) 是一个带带的小岛.更多相关视频
相关概念视频
Myasthenia Gravis: Diagnostic Tests
673
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
673
Myocarditis II: Clinical features and Diagnostic Tests
2
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K


